Skip to main content
. 2016 May 30;7(28):43868–43893. doi: 10.18632/oncotarget.9701

Table 8. Relationship between Transgelin expression and clinicopathological features of Stage III CRC.

Variables Number (n) Transgelin expression p-value
Positive (n=84) Negative (n=108)
Gender 0.461
Male 112 52 60
Female 80 32 48
Ages (years) 0.841
>=65 91 41 50
<65 101 43 58
Tumor location 0.767
ascending colon 97 42 55
transverse colon 7 4 3
descending colon 88 38 50
CEA level (mg/L) 7.11±7.45 22.11±32.87 <0.001*
Tumor differentiation 0.285
Well 21 7 14
Moderate 135 64 71
Poor 36 13 23
AJCC stage 0.027*
IIIA 7 5 2
IIIB 124 60 64
IIIC 61 19 42
*

Statistically significant (p<0.05)